In this paper by King and colleagues (BMJ 2021;373:n1014, doi:10.1136/bmj.n1014, published 12 May 2021), the participants from the Heart of England NHS Foundation Trust were omitted […]
The U.S. Food and Drug Administration (FDA) recently approved aducanumab, the first treatment that aims to slow the progression of Alzheimer’s disease. But approval of the […]